Related Experiment Video
Updated: Aug 19, 2025

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.3K
Tools for communicating risk for Parkinson's disease
Lola Cook1, Jeanine Schulze2, Wendy R Uhlmann3
1Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA. lpcook@iu.edu.
NPJ Parkinson'S Disease
|November 29, 2022
Summary
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
660
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
660
Parkinson's Disease: Treatment
345
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
345

